Journal of the Anus Rectum and Colon· 2026Q2
Gut Microbiota Profiles in Diarrhea-Predominant Irritable Bowel Syndrome and Their Relationship to Clinical Efficacy of Hangeshashinto: The GMIBS-HA Study
- 0citations
- Q2SCImago
- 2026year
Short summary
This study identified specific gut microbiota associated with diarrhea-predominant IBS (IBS-D) and evaluated how changes in these microbes correlate with clinical improvement after treatment with Hangeshashinto (HST).
AI-generated from the title and abstract; the full text is not read.
Key points
- Identified specific gut microbiota profiles associated with diarrhea-predominant IBS (IBS-D).
- Evaluated clinical improvement in IBS-D patients following Hangeshashinto (HST) treatment.
- Investigated the relationship between changes in gut microbiota abundance and clinical efficacy of HST.
AI-generated from the title and abstract; the full text is not read.
Abstract
Objectives: This study aimed to identify specific microbiota associated with diarrhea-predominant irritable bowel syndrome (IBS-D) and to evaluate clinical improvement in IBS-D according to changes in gut microbiota abundance following treatment with Hangeshashinto (HST), an anti-inflammatory Kampo medicine.
The authors' abstract, as published at the source. Journal of the Anus Rectum and Colon, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Gastroenterology
GastroenterologyMedicine